城乡居民“两病”政策落地情况实证研究  

Empirical study on the implementation of outpatient medication guarantee policy for diabetes and hypertension in urban and rural residents

作　　者：吴丽萍[1] 丁锦希[1] 陈烨[1] 柳婷[1] 唐迪 WU Liping;DING Jinxi;CHEN Ye;LIU Ting;TANG Di(China Pharmaceutical University,Nanjing 211198,China)

机构地区：[1]中国药科大学,南京211198

出　　处：《上海医药》2022年第5期69-72,共4页Shanghai Medical & Pharmaceutical Journal

摘　　要：糖尿病、高血压(简称“两病”)由于并发症多、易复发、治疗周期长且较难根治,患者通常面临沉重的疾病经济负担。因此,为进一步保障“两病”患者的门诊补偿水平,国家医疗保障局联合3部门出台了《关于完善城乡居民高血压糖尿病门诊用药保障机制的指导意见》。本文通过探讨该城乡居民“两病”政策的落地情况,发现其促使“两病”门诊用药的保障范围扩大、保障水平提高的同时将引起医保基金支出的骤增,各统筹地区可通过开展专项集中采购、完善医疗服务管理等措施达到控费效果。Due to many complications,easy recurrence,long treatment cycles and difficult cure,patients with diabetes and hypertension(referred to as the“two diseases”)usually face a heavy economic burden.Therefore,the National Health Security Administration in conjunction with three departments issued the“Outpatient Medication Guarantee Policy for Diabetes and Hypertension in Urban and Rural Residents”to further ensure the level of outpatient compensation for patients with“two diseases”.This paper discusses the implementation of the“two diseases”policy and finds that it will expand the coverage of outpatient medication for“two diseases”and improve the level of protection,but will lead to a sharp increase in medical insurance fund expenditures.Measures such as centralized procurement and improvement of medical service management should be taken to achieve the effect of cost control.

关 键 词：“两病” 门诊医保补偿 城乡居民 

分 类 号：R19-0[医药卫生—卫生事业管理]